Tekla Capital Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2020
Q3 | – | Sell |
-71,340
| Closed | -$744K | – | 217 |
|
2020
Q2 | $744K | Hold |
71,340
| – | – | 0.03% | 204 |
|
2020
Q1 | $602K | Hold |
71,340
| – | – | 0.03% | 190 |
|
2019
Q4 | $624K | Hold |
71,340
| – | – | 0.02% | 190 |
|
2019
Q3 | $768K | Hold |
71,340
| – | – | 0.03% | 168 |
|
2019
Q2 | $907K | Hold |
71,340
| – | – | 0.04% | 169 |
|
2019
Q1 | $2.77M | Sell |
71,340
-12,000
| -14% | -$465K | 0.11% | 120 |
|
2018
Q4 | $1.7M | Hold |
83,340
| – | – | 0.07% | 138 |
|
2018
Q3 | $3.82M | Hold |
83,340
| – | – | 0.14% | 110 |
|
2018
Q2 | $4.93M | Buy |
83,340
+27,355
| +49% | +$1.62M | 0.19% | 93 |
|
2018
Q1 | $3.81M | Buy |
55,985
+7,593
| +16% | +$517K | 0.15% | 103 |
|
2017
Q4 | $4.78M | Sell |
48,392
-57,103
| -54% | -$5.65M | 0.18% | 95 |
|
2017
Q3 | $12.6M | Sell |
105,495
-97,042
| -48% | -$11.6M | 0.45% | 46 |
|
2017
Q2 | $17.7M | Sell |
202,537
-57,663
| -22% | -$5.04M | 0.66% | 33 |
|
2017
Q1 | $9.68M | Hold |
260,200
| – | – | 0.38% | 60 |
|
2016
Q4 | $7.99M | Hold |
260,200
| – | – | 0.34% | 65 |
|
2016
Q3 | $17.4M | Hold |
260,200
| – | – | 0.67% | 34 |
|
2016
Q2 | $7.75M | Hold |
260,200
| – | – | 0.32% | 67 |
|
2016
Q1 | $7.64M | Hold |
260,200
| – | – | 0.33% | 67 |
|
2015
Q4 | $20.4M | Buy |
260,200
+165,000
| +173% | +$12.9M | 0.74% | 28 |
|
2015
Q3 | $7.17M | Buy |
+95,200
| New | +$7.17M | 0.26% | 75 |
|
2014
Q2 | – | Sell |
-185,820
| Closed | -$19.4M | – | 65 |
|
2014
Q1 | $19.4M | Hold |
185,820
| – | – | 1.93% | 16 |
|
2013
Q4 | $19.2M | Sell |
185,820
-272,996
| -60% | -$28.3M | 2.02% | 15 |
|
2013
Q3 | $24.6M | Sell |
458,816
-252,984
| -36% | -$13.6M | 2.74% | 9 |
|
2013
Q2 | $31.6M | Buy |
+711,800
| New | +$31.6M | 4.29% | 7 |
|